chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vial was initially stored in the refrigerator on 10-JUN-2022 and vaccine was administered on 11-Jul-2022; booster dose administered to patient after use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (booster dose administered to patient after use by date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 10-JUN-2022 and vaccine was administered on 11-Jul-2022) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Janssen COVID-19 VACCINE (primary series). Past adverse reactions to the above products included No adverse event with Janssen COVID-19 VACCINE.  On 11-Jul-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (booster dose administered to patient after use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 10-JUN-2022 and vaccine was administered on 11-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (booster dose administered to patient after use by date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 10-JUN-2022 and vaccine was administered on 11-Jul-2022) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Patients had received their 1st booster dose of the Moderna COVID-19 vaccine after the use by date.  The vial was initially stored in the refrigerator on 10-JUN-2022. The vial did not undergo any temperature excursions.  BUD in refrigerator was on 10-Jul-2022 at 10am.  Patients had not reported any adverse reactions post vaccination.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Immunisation reaction
Clinical narrative: experienced a "reaction" to the Moderna Covid -19 vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (experienced a "reaction" to the Moderna Covid -19 vaccine.) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (experienced a "reaction" to the Moderna Covid -19 vaccine.). At the time of the report, IMMUNISATION REACTION (experienced a "reaction" to the Moderna Covid -19 vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. It was reported that patient occupation reported as ultrasound technician. The caller does not have any other information on the patient or the doses of patient's vaccine. No concomitant medication were reported. No treatment information were reported.   Reporter did not allow further contact
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.; Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 07-Jul-2022.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. 5 vials were involved and 9 doses were administered to patients. on 02-Jun-2022 vial was initially stored in the refrigerator and vaccine was administered on 07-Jul-2022. It was reported that patient received second booster dose. The vial does not undergo any temperature excursions. Treatment details were not reported by the reporter.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 08-Jul-2022.; Moderna vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 08-Jul-2022.) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.   No Medical History information was reported.  On 08-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 08-Jul-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 02-Jun-2022 and vaccine was administered on 08-Jul-2022.) outcome was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. The vial was initially stored in the refrigerator on 02 Jun 2022. The vial did not undergo any temperature excursions. No treatment medications were provided.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: (Moderna) Vaccine was given beyond the refrigeration use; (Moderna) Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use). At the time of the report, EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. The vial was initially stored in the refrigerator on 02-Jun-2022. The vial does not undergo any temperature excursions. No treatment medications was reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: (Moderna) Vaccine was given beyond the refrigeration use; (Moderna) Vaccine was given beyond the refrigeration use; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Jul-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use). At the time of the report, EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment medications was reported.  The vial was initially stored in the refrigerator on 02-Jun-2022. The vial does not undergo any temperature excursions.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: initially stored in the refrigerator JUNE 02 2022 and the vaccine was given on 11 July 2022; Moderna Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (initially stored in the refrigerator JUNE 02 2022 and the vaccine was given on 11 July 2022) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (initially stored in the refrigerator JUNE 02 2022 and the vaccine was given on 11 July 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (initially stored in the refrigerator JUNE 02 2022 and the vaccine was given on 11 July 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided. The vial was initially stored in the refrigerator on 02 Jun 2022. The vial did not undergo any temperature excursions. No treatment medications were provided.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Moderna Vaccine was given beyond the refrigeration use; Moderna Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (Moderna Vaccine was given beyond the refrigeration use) in a 34-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 014B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jul-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Vaccine was given beyond the refrigeration use). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR (Moderna Vaccine was given beyond the refrigeration use) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  The vial was initially stored in the refrigerator on 02-Jun-2022  The vial did not undergo any temperature excursion.  Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: (Moderna) Vaccine was given beyond the refrigeration use; (Moderna) Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use). At the time of the report, EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. The vial was initially stored in the refrigerator on 02-Jun-2022. The vial does not undergo any temperature excursions. No treatment medications was reported.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine normal, Blood magnesium increased, Blood urea, C-reactive protein normal, COVID-19
Clinical narrative: 14-year-old male patient complained of increased rectal bleeding beginning yesterday. Has a history of ulcerative colitis (diagnosed November 2021). He has had a mild cough and increased nasal congestion. Patient was hypertensive at 152/69. CBC and CMP significant for WBC of 12.05, SED rate 36, BUN 6, creatinine 0.9, magnesium 2.5, CRP 0.48, and positive COVID-19 swab. Patient received 40mg solumedrol and 1L NS bolus. He was discharged in stable condition on 01/23/2022.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Full blood count abnormal, Hypertension, Metabolic function test abnormal, Nasal congestion
Clinical narrative: 14-year-old male patient complained of increased rectal bleeding beginning yesterday. Has a history of ulcerative colitis (diagnosed November 2021). He has had a mild cough and increased nasal congestion. Patient was hypertensive at 152/69. CBC and CMP significant for WBC of 12.05, SED rate 36, BUN 6, creatinine 0.9, magnesium 2.5, CRP 0.48, and positive COVID-19 swab. Patient received 40mg solumedrol and 1L NS bolus. He was discharged in stable condition on 01/23/2022.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Rectal haemorrhage, Red blood cell sedimentation rate increased, SARS-CoV-2 test positive, White blood cell count increased
Clinical narrative: 14-year-old male patient complained of increased rectal bleeding beginning yesterday. Has a history of ulcerative colitis (diagnosed November 2021). He has had a mild cough and increased nasal congestion. Patient was hypertensive at 152/69. CBC and CMP significant for WBC of 12.05, SED rate 36, BUN 6, creatinine 0.9, magnesium 2.5, CRP 0.48, and positive COVID-19 swab. Patient received 40mg solumedrol and 1L NS bolus. He was discharged in stable condition on 01/23/2022.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Dermatitis allergic, Injection site erythema, Injection site swelling, Rash
Clinical narrative: Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Rash Generalized-Mild
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Paranasal sinus mass
Clinical narrative: I have a mass growing in my left nostril. I can't prove it, but I highly suspect this is a result of this vaccine I was mandated to get.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location).
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Blood creatinine increased, Blood glucose increased, C-reactive protein increased, COVID-19
Clinical narrative: Apparently a day prior to presentation he had a mechanical fall at the living facility where he resides .  In the ER he was noted to be hypoxic COVID-19 testing came back positive Seen with some lactic acidosis, with creatinine elevated to 1.4, he was commenced on steroid.  Discharge diagnosis :  Acute encephalopathy COVID-19 infection Acute renal failure Elevated blood sugars Elevated CRP Lactic acidosis resolved
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Dyspnoea, Encephalopathy, Fall, Hypoxia
Clinical narrative: Apparently a day prior to presentation he had a mechanical fall at the living facility where he resides .  In the ER he was noted to be hypoxic COVID-19 testing came back positive Seen with some lactic acidosis, with creatinine elevated to 1.4, he was commenced on steroid.  Discharge diagnosis :  Acute encephalopathy COVID-19 infection Acute renal failure Elevated blood sugars Elevated CRP Lactic acidosis resolved
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Lactic acidosis, Lung hypoinflation, SARS-CoV-2 test positive
Clinical narrative: Apparently a day prior to presentation he had a mechanical fall at the living facility where he resides .  In the ER he was noted to be hypoxic COVID-19 testing came back positive Seen with some lactic acidosis, with creatinine elevated to 1.4, he was commenced on steroid.  Discharge diagnosis :  Acute encephalopathy COVID-19 infection Acute renal failure Elevated blood sugars Elevated CRP Lactic acidosis resolved
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 61.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site swelling, Rash
Clinical narrative: Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: patient entire arm from deltoid to above elbow red, hot and swollen-she put ice said felt better so i advised her to take benadryl and follow up with me on sunday july 17
Age: 50.0
Sex: M
Vaccine: VARZOS
Symptoms: Injected limb mobility decreased, Injection site pain, Injection site swelling, Nodule, Peripheral swelling
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: Patient reports he cannot move his left shoulder today after receiving Shingrix and Moderna COVID-19 vaccine yesterday. Reports feeling like he has two knots in his left arm and it is swollen.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Administered expired product.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Extra dose administered
Clinical narrative: Patient received a 3rd dose of Shingrix 7/18/22. Dose #1 received 12/03/20. Dose #2 received 5/13/21.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Ear pain, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Tested positive for Covid on a home test. Had sore throat and ear ache.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid 19 pcr positive for 8/5/2021. Narrative:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, Bacterial infection, Blood creatinine increased, Blood culture positive
Clinical narrative: Patient presented to the emergency department with fatigue weakness and shortness of breath.  He also had an episode of falling to the ground.   His workup in the ER was noted to be febrile and hypoxic on room air at 88%.  He was found to be COVID-19 positive, D-dimer was elevated and nearly 10,000, white blood cell count was 8,000, BUN/Cr are 51/3.2 which is slightly worse than his baseline creatinine of mid to upper 2s, procalcitonin is elevated at 38, high sensitivity troponin was mildly elevated at 67 which peaked at 98 and now is down to 53, chest x-ray noted ill-defined patchy opacities in the bilateral lower lobes.  He was admitted and started on dexamethasone, intravenous antibiotics including cefepime and vancomycin, and a heparin drip given his elevated D-dimer but no CTA was completed due to his elevated creatinine.  He was also started on Remdesivir.   Vancomycin has been changed to doxycycline.  December 17, blood culture is positive for proteus, pan sensitive. Urine culture is positive for Gram negative rods. He is on cefepime.  Pulmonology has indicated no indication for anticoagulation nor doxycycline and stopped Remdesivir in light of CKD. Both are stopped. WBC is 21. Repeat blood culture is ordered. D Dimer improved to 4,500 from 10,000.  December 20, he is discharged home on ciprofloxacin 500 mg daily and dexamethasone 6 mg daily for five additional days. His amlodipine was stopped and nifedipine started for HTN.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urea increased, COVID-19, Chest X-ray abnormal, Culture urine positive, Dyspnoea
Clinical narrative: Patient presented to the emergency department with fatigue weakness and shortness of breath.  He also had an episode of falling to the ground.   His workup in the ER was noted to be febrile and hypoxic on room air at 88%.  He was found to be COVID-19 positive, D-dimer was elevated and nearly 10,000, white blood cell count was 8,000, BUN/Cr are 51/3.2 which is slightly worse than his baseline creatinine of mid to upper 2s, procalcitonin is elevated at 38, high sensitivity troponin was mildly elevated at 67 which peaked at 98 and now is down to 53, chest x-ray noted ill-defined patchy opacities in the bilateral lower lobes.  He was admitted and started on dexamethasone, intravenous antibiotics including cefepime and vancomycin, and a heparin drip given his elevated D-dimer but no CTA was completed due to his elevated creatinine.  He was also started on Remdesivir.   Vancomycin has been changed to doxycycline.  December 17, blood culture is positive for proteus, pan sensitive. Urine culture is positive for Gram negative rods. He is on cefepime.  Pulmonology has indicated no indication for anticoagulation nor doxycycline and stopped Remdesivir in light of CKD. Both are stopped. WBC is 21. Repeat blood culture is ordered. D Dimer improved to 4,500 from 10,000.  December 20, he is discharged home on ciprofloxacin 500 mg daily and dexamethasone 6 mg daily for five additional days. His amlodipine was stopped and nifedipine started for HTN.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Fatigue, Fibrin D dimer increased, Hypoxia, Lung opacity
Clinical narrative: Patient presented to the emergency department with fatigue weakness and shortness of breath.  He also had an episode of falling to the ground.   His workup in the ER was noted to be febrile and hypoxic on room air at 88%.  He was found to be COVID-19 positive, D-dimer was elevated and nearly 10,000, white blood cell count was 8,000, BUN/Cr are 51/3.2 which is slightly worse than his baseline creatinine of mid to upper 2s, procalcitonin is elevated at 38, high sensitivity troponin was mildly elevated at 67 which peaked at 98 and now is down to 53, chest x-ray noted ill-defined patchy opacities in the bilateral lower lobes.  He was admitted and started on dexamethasone, intravenous antibiotics including cefepime and vancomycin, and a heparin drip given his elevated D-dimer but no CTA was completed due to his elevated creatinine.  He was also started on Remdesivir.   Vancomycin has been changed to doxycycline.  December 17, blood culture is positive for proteus, pan sensitive. Urine culture is positive for Gram negative rods. He is on cefepime.  Pulmonology has indicated no indication for anticoagulation nor doxycycline and stopped Remdesivir in light of CKD. Both are stopped. WBC is 21. Repeat blood culture is ordered. D Dimer improved to 4,500 from 10,000.  December 20, he is discharged home on ciprofloxacin 500 mg daily and dexamethasone 6 mg daily for five additional days. His amlodipine was stopped and nifedipine started for HTN.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin, Proteus test positive, Pyrexia, SARS-CoV-2 test positive, Troponin
Clinical narrative: Patient presented to the emergency department with fatigue weakness and shortness of breath.  He also had an episode of falling to the ground.   His workup in the ER was noted to be febrile and hypoxic on room air at 88%.  He was found to be COVID-19 positive, D-dimer was elevated and nearly 10,000, white blood cell count was 8,000, BUN/Cr are 51/3.2 which is slightly worse than his baseline creatinine of mid to upper 2s, procalcitonin is elevated at 38, high sensitivity troponin was mildly elevated at 67 which peaked at 98 and now is down to 53, chest x-ray noted ill-defined patchy opacities in the bilateral lower lobes.  He was admitted and started on dexamethasone, intravenous antibiotics including cefepime and vancomycin, and a heparin drip given his elevated D-dimer but no CTA was completed due to his elevated creatinine.  He was also started on Remdesivir.   Vancomycin has been changed to doxycycline.  December 17, blood culture is positive for proteus, pan sensitive. Urine culture is positive for Gram negative rods. He is on cefepime.  Pulmonology has indicated no indication for anticoagulation nor doxycycline and stopped Remdesivir in light of CKD. Both are stopped. WBC is 21. Repeat blood culture is ordered. D Dimer improved to 4,500 from 10,000.  December 20, he is discharged home on ciprofloxacin 500 mg daily and dexamethasone 6 mg daily for five additional days. His amlodipine was stopped and nifedipine started for HTN.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Patient presented to the emergency department with fatigue weakness and shortness of breath.  He also had an episode of falling to the ground.   His workup in the ER was noted to be febrile and hypoxic on room air at 88%.  He was found to be COVID-19 positive, D-dimer was elevated and nearly 10,000, white blood cell count was 8,000, BUN/Cr are 51/3.2 which is slightly worse than his baseline creatinine of mid to upper 2s, procalcitonin is elevated at 38, high sensitivity troponin was mildly elevated at 67 which peaked at 98 and now is down to 53, chest x-ray noted ill-defined patchy opacities in the bilateral lower lobes.  He was admitted and started on dexamethasone, intravenous antibiotics including cefepime and vancomycin, and a heparin drip given his elevated D-dimer but no CTA was completed due to his elevated creatinine.  He was also started on Remdesivir.   Vancomycin has been changed to doxycycline.  December 17, blood culture is positive for proteus, pan sensitive. Urine culture is positive for Gram negative rods. He is on cefepime.  Pulmonology has indicated no indication for anticoagulation nor doxycycline and stopped Remdesivir in light of CKD. Both are stopped. WBC is 21. Repeat blood culture is ordered. D Dimer improved to 4,500 from 10,000.  December 20, he is discharged home on ciprofloxacin 500 mg daily and dexamethasone 6 mg daily for five additional days. His amlodipine was stopped and nifedipine started for HTN.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthropod bite, Erythema, Injection site reaction, Pallor, Rash erythematous
Clinical narrative: Received Pfizer COVID vaccine 7/2/22. Her mother notes that she first saw the red bumps the next day. Per mom, got "insect bites" 2 weeks ago. A few days ago they flared up after going to a water park. They were near the diaper area - four of them swelled up.  She has had no fever, no illness over the past month.     She describes the rash that appeared 2 days ago had spreading redness with central pallor and a red raised circular redness that is itchy. The first ones on her lateral thighs improved after using hydrocortisone topically, but other ones the next day increased.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash papular, Rash pruritic
Clinical narrative: Received Pfizer COVID vaccine 7/2/22. Her mother notes that she first saw the red bumps the next day. Per mom, got "insect bites" 2 weeks ago. A few days ago they flared up after going to a water park. They were near the diaper area - four of them swelled up.  She has had no fever, no illness over the past month.     She describes the rash that appeared 2 days ago had spreading redness with central pallor and a red raised circular redness that is itchy. The first ones on her lateral thighs improved after using hydrocortisone topically, but other ones the next day increased.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Erythema multiforme, Pallor, Rash macular, Rash papular
Clinical narrative: Received Pfizer COVID vaccine 7/2/22. Her mother notes that she first saw the red bumps the next day. Per mom, got "insect bites" 2 weeks ago. A few days ago they flared up after going to a water park. They were near the diaper area - four of them swelled up.  She has had no fever, no illness over the past month.     She describes the rash that appeared 2 days ago had spreading redness with central pallor and a red raised circular redness that is itchy. The first ones on her lateral thighs improved after using hydrocortisone topically, but other ones the next day increased.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash pruritic, Skin discolouration, Skin lesion, Urticaria
Clinical narrative: Received Pfizer COVID vaccine 7/2/22. Her mother notes that she first saw the red bumps the next day. Per mom, got "insect bites" 2 weeks ago. A few days ago they flared up after going to a water park. They were near the diaper area - four of them swelled up.  She has had no fever, no illness over the past month.     She describes the rash that appeared 2 days ago had spreading redness with central pallor and a red raised circular redness that is itchy. The first ones on her lateral thighs improved after using hydrocortisone topically, but other ones the next day increased.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthropod bite, Erythema, Injection site reaction, Pallor, Rash erythematous
Clinical narrative: Seen on 7/18/22 and diagnosed with erythema multiforme. Pt has areas of bluish circular hues around thighs on lateral bilateral thighs, inner left thigh has two circular lesions with circumferential erythema and central pallor. Symptoms started day after vaccine. Mom noticed four red welts near her diaper area on 7/3/22. Spots persisted. On 7/16/22, the rash had spreading redness with central pallor and a red raised circular redness that is itchy. The first ones on her lateral thighs improved after using hydrocortisone topically, but other ones the next day increased.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash papular, Rash pruritic
Clinical narrative: Seen on 7/18/22 and diagnosed with erythema multiforme. Pt has areas of bluish circular hues around thighs on lateral bilateral thighs, inner left thigh has two circular lesions with circumferential erythema and central pallor. Symptoms started day after vaccine. Mom noticed four red welts near her diaper area on 7/3/22. Spots persisted. On 7/16/22, the rash had spreading redness with central pallor and a red raised circular redness that is itchy. The first ones on her lateral thighs improved after using hydrocortisone topically, but other ones the next day increased.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Erythema multiforme, Pallor, Rash macular, Rash papular
Clinical narrative: Seen on 7/18/22 and diagnosed with erythema multiforme. Pt has areas of bluish circular hues around thighs on lateral bilateral thighs, inner left thigh has two circular lesions with circumferential erythema and central pallor. Symptoms started day after vaccine. Mom noticed four red welts near her diaper area on 7/3/22. Spots persisted. On 7/16/22, the rash had spreading redness with central pallor and a red raised circular redness that is itchy. The first ones on her lateral thighs improved after using hydrocortisone topically, but other ones the next day increased.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash pruritic, Skin discolouration, Skin lesion, Urticaria
Clinical narrative: Seen on 7/18/22 and diagnosed with erythema multiforme. Pt has areas of bluish circular hues around thighs on lateral bilateral thighs, inner left thigh has two circular lesions with circumferential erythema and central pallor. Symptoms started day after vaccine. Mom noticed four red welts near her diaper area on 7/3/22. Spots persisted. On 7/16/22, the rash had spreading redness with central pallor and a red raised circular redness that is itchy. The first ones on her lateral thighs improved after using hydrocortisone topically, but other ones the next day increased.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Gait disturbance, Limb discomfort, Pain, Sleep disorder
Clinical narrative: Severe Burning as it enters my arm.  2 days later, both legs became very heavy, hard to walk and painful enough to keep me up all night for nights on end.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Surgery, Ultrasound scan abnormal, Varicose vein
Clinical narrative: Severe Burning as it enters my arm.  2 days later, both legs became very heavy, hard to walk and painful enough to keep me up all night for nights on end.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Asthenia, COVID-19, Chest discomfort, Cough
Clinical narrative: Patient admitted due to shortness of breath.  Per patient she had just received COVID-19 vaccine on 11/10/2021, subsequently 2 days after she tested positive to COVID-19 infection with shortness of breath and cough with chest discomfort.  CTA of the chest was negative for PE.  Patient was exhausted from severe weakness from COVID-19 infection.  Of note, patient has a history of dizziness vital ago and has been on meclizine for symptomatic management.  Suspect had similar episode at the ER  During this entire hospitalization she had no chest pain no shortness of breath no dizziness did not feel faint.  Recommend outpatient follow-up family doctor regarding syncope.  She received Decadron, Remdesivir and Baricitiinib during this hospitalization responded well to treatment and was discharged in stable condition
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, SARS-CoV-2 test positive, Syncope
Clinical narrative: Patient admitted due to shortness of breath.  Per patient she had just received COVID-19 vaccine on 11/10/2021, subsequently 2 days after she tested positive to COVID-19 infection with shortness of breath and cough with chest discomfort.  CTA of the chest was negative for PE.  Patient was exhausted from severe weakness from COVID-19 infection.  Of note, patient has a history of dizziness vital ago and has been on meclizine for symptomatic management.  Suspect had similar episode at the ER  During this entire hospitalization she had no chest pain no shortness of breath no dizziness did not feel faint.  Recommend outpatient follow-up family doctor regarding syncope.  She received Decadron, Remdesivir and Baricitiinib during this hospitalization responded well to treatment and was discharged in stable condition
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune disorder, Blood test abnormal, Blood urine present, Chills, Chromaturia
Clinical narrative: woke up with a fever early morning,3/1/22. Along with chills, aches, dry heaves, I noticed my urine was cola colored. .(presence of blood). Blood labs done on 3/2/22 showed many abnormalities. Most resolved in a few weeks..But abnormal kidney functions remain. And was newly diagnosed with a autoimmune  kidney disease. Was told Kidney?s were functioning at 39%.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Renal disorder, Renal impairment, Retching
Clinical narrative: woke up with a fever early morning,3/1/22. Along with chills, aches, dry heaves, I noticed my urine was cola colored. .(presence of blood). Blood labs done on 3/2/22 showed many abnormalities. Most resolved in a few weeks..But abnormal kidney functions remain. And was newly diagnosed with a autoimmune  kidney disease. Was told Kidney?s were functioning at 39%.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, Urine analysis
Clinical narrative: woke up with a fever early morning,3/1/22. Along with chills, aches, dry heaves, I noticed my urine was cola colored. .(presence of blood). Blood labs done on 3/2/22 showed many abnormalities. Most resolved in a few weeks..But abnormal kidney functions remain. And was newly diagnosed with a autoimmune  kidney disease. Was told Kidney?s were functioning at 39%.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Hospitalization, unrelated to COVID, tested prior to nursing home placement for rehabilitation.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Headache, Nausea
Clinical narrative: nausea, headache, stomachache
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Tinnitus
Clinical narrative: Tinnitus, fatigue
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient came to clinic for a Moderna booster, which was provided the same day on 7/5/2022. Later when doing vaccine reconciliation it was noted to be past the 30 day window of administration. This lot number had an expiration date of 10/15/2022. It arrived after ordering on 5/10/2022, so the last use-by date should have been 6/10/2022. 7/5/2022 falls outside of the last use-by date. Patient was called. No adverse effects. No recovery required. Moderna was called and verified he would not need to be revaccinated. The lot number was still effective.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID-19.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Break through COVID
Age: 30.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Dizziness, Paraesthesia
Clinical narrative: After receiving first dose patient states " i feel really lightheaded and tingling sensation. ".  Vital sighs initiated, Ice packs applied
Age: 11.0
Sex: F
Vaccine: MENB
Symptoms: Unevaluable event
Clinical narrative: NONE
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Break through COVID
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was administered after the Beyond Use Date for refrigerator storage.
Age: 19.0
Sex: F
Vaccine: MENB
Symptoms: Back pain, Chills, Loss of consciousness, Malaise, Pyrexia
Clinical narrative: The evening of 7/15/22 pt did not feel well, had chills and a pain in lower back and went to bed. Pt sitting at breakfast table 7/16/22 and passed out briefly. Pt vomited then was taken via ambulance to ER.  Pt also reported having fever, shaking, chills, vomiting, and losing feeling in her hands.
Age: 19.0
Sex: F
Vaccine: MENB
Symptoms: Sensory loss, Tremor, Vomiting
Clinical narrative: The evening of 7/15/22 pt did not feel well, had chills and a pain in lower back and went to bed. Pt sitting at breakfast table 7/16/22 and passed out briefly. Pt vomited then was taken via ambulance to ER.  Pt also reported having fever, shaking, chills, vomiting, and losing feeling in her hands.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was administered after the Beyond Use Date for refrigerator storage.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was given to COVID19 Moderna Booster dose of 0.25ml at an age that it is not yet approved for (at age 14). She had previously received Pfizer Peds primary two dose series.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Received unapproved 2nd COVID-19 vaccine booster. No adverse reactions noted.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Diastolic dysfunction, Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: Pt admitted 7/12 for induction of labor and delivered healthy infant. Discharged on 7/14. Received Pfizer COVID vaccine on 7/14 per patient. Initial vaccination was with Janssen; first booster was Moderna, and second booster was Pfizer on 7/14.  On 7/16 developed fever, trouble breathing while lying down and R sided chest heaviness/pressure. Found to be hypoxic and hypertensive upon arrival in ED.  At first, felt to be pre-eclampsia with fluid overload +/- postpartum cardiomyopathy. Cardiology consulted. Echocardiogram showed mildly reduced EF consistent with myocarditis, slight troponin rise. Cardiologist's note states "I suspect this is related to the COVID-9 vaccination." She was started on low-dose ACE inhibitor. Pt discahrged to home on 7/18/22 on enalapril 5 mg PO daily.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Hypervolaemia, Hypoxia, Immunisation reaction, Interchange of vaccine products
Clinical narrative: Pt admitted 7/12 for induction of labor and delivered healthy infant. Discharged on 7/14. Received Pfizer COVID vaccine on 7/14 per patient. Initial vaccination was with Janssen; first booster was Moderna, and second booster was Pfizer on 7/14.  On 7/16 developed fever, trouble breathing while lying down and R sided chest heaviness/pressure. Found to be hypoxic and hypertensive upon arrival in ED.  At first, felt to be pre-eclampsia with fluid overload +/- postpartum cardiomyopathy. Cardiology consulted. Echocardiogram showed mildly reduced EF consistent with myocarditis, slight troponin rise. Cardiologist's note states "I suspect this is related to the COVID-9 vaccination." She was started on low-dose ACE inhibitor. Pt discahrged to home on 7/18/22 on enalapril 5 mg PO daily.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Myocarditis, Peripartum cardiomyopathy, Pre-eclampsia, Pyrexia, Troponin increased
Clinical narrative: Pt admitted 7/12 for induction of labor and delivered healthy infant. Discharged on 7/14. Received Pfizer COVID vaccine on 7/14 per patient. Initial vaccination was with Janssen; first booster was Moderna, and second booster was Pfizer on 7/14.  On 7/16 developed fever, trouble breathing while lying down and R sided chest heaviness/pressure. Found to be hypoxic and hypertensive upon arrival in ED.  At first, felt to be pre-eclampsia with fluid overload +/- postpartum cardiomyopathy. Cardiology consulted. Echocardiogram showed mildly reduced EF consistent with myocarditis, slight troponin rise. Cardiologist's note states "I suspect this is related to the COVID-9 vaccination." She was started on low-dose ACE inhibitor. Pt discahrged to home on 7/18/22 on enalapril 5 mg PO daily.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Break Through COVID
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Insomnia, Nasal congestion
Clinical narrative: Ache all over, stuffy head, cough with heavy phlegm, trouble sleeping at onset day zero; gradually felt better until day 5 when felt tired all over; started paxlovid on day 5; positive at home tests on day 2 and day five; negative test on day 8 and feeling fine (day 8 equals day 4 of paxlovid which I will finish on its 5 day course).
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Productive cough, SARS-CoV-2 test positive
Clinical narrative: Ache all over, stuffy head, cough with heavy phlegm, trouble sleeping at onset day zero; gradually felt better until day 5 when felt tired all over; started paxlovid on day 5; positive at home tests on day 2 and day five; negative test on day 8 and feeling fine (day 8 equals day 4 of paxlovid which I will finish on its 5 day course).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Endometrial thickening, Fatigue, Mobility decreased, Pain
Clinical narrative: I was walking in the evening and walked about a block and a half. All the sudden I had excruciating pain form my hip to my leg and had to basically drag myself home. It was like that for over a day so I called my doctor and they had me come in. They did hip X-rays of both hips. They couldn't see anything so he did a physical exam and found the most pain in my bursa and it's causing sciatica down my leg.  I sued to be a morning person and now I wake up tired and need coffee. I feel 80 years old when I wake up and it takes a lot of walking around and stretching to feel okay again. After a few weeks, I was still in pain everywhere so my doctor referred me to an Orthopedic doctor who gave me a cortisone injection in my hip. The next morning I was able to walk like a normal person again. My doctor explained that a pain somewhere in the body can go through your joints and cause pain all over. I got 600mg Motrin but I don't like to take medication. He told me it would heal in a few weeks. He also gave me physical exercises to do to help heal it. I am still waiting to feel like myself again and it's been three months. I am still having issues. A few weeks ago , I also started spotting. I haven't had my period in many years so it was freaky. Now, they want to do a biopsy. I didn't have any other symptoms but the spotting lasted about 3-4 days. My doctor did an ultrasound and found the lining of my uterus was thicker than normal.